Cargando…
Injection of immunoglobulin in the treatment process of children with severe pneumonia
OBJECTIVE: To observe the effect of intravenous infusion of immune globulin in the treatment of children with severe pneumonia. METHODS: Ninety-eight children with severe pneumonia who received treatment in our hospital between April 2015 and December 2016 were selected, and they were grouped into a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659095/ https://www.ncbi.nlm.nih.gov/pubmed/31372121 http://dx.doi.org/10.12669/pjms.35.4.83 |
_version_ | 1783439069978558464 |
---|---|
author | Chen, Liping Qi, Xuehai Li, Ruiying Wang, Xudong Shi, Baohai Meng, Qingmei |
author_facet | Chen, Liping Qi, Xuehai Li, Ruiying Wang, Xudong Shi, Baohai Meng, Qingmei |
author_sort | Chen, Liping |
collection | PubMed |
description | OBJECTIVE: To observe the effect of intravenous infusion of immune globulin in the treatment of children with severe pneumonia. METHODS: Ninety-eight children with severe pneumonia who received treatment in our hospital between April 2015 and December 2016 were selected, and they were grouped into a control group and an treatment group, 49 each group. The control group received conventional treatment. The treatment group was additionally treated with immune globulin on the basis of conventional treatment. The humoral immune indicators were detected using immunoturbidimetric assay, and the inflammatory reaction indicators were detected using enzyme-linked immunoabsorbent kit. The overall efficacy, clinical symptoms, humoral immunity and inflammatory response were compared between the two groups. RESULTS: The total effective rate of the treatment group was significantly higher than that of the control group (P<0.05). The cough, rale and fever of the treatment group disappeared faster than those of the control group, the relief of cardiac failure was also faster in the treatment group (P<0.05). The immunoglobulin G (Ig G), Ig A and Ig M of patients in the two groups compared before treatment, and no significant difference was found (P>0.05). The Ig G level of the treatment group was higher than that of the control group after treatment (P<0.05). The comparison of Ig A and Ig M between the two groups indicated no significant difference (P>0.05). The two groups had no significant differences in the content of tumor necrosis factor (TNF)-α, C-reactive protein (CRP), soluble intercellular adhesion molecule (SICAM)-1 and interferon (IFN)-γ (P>0.05) before treatment, but the content of the treatment group was significantly higher than that of the control group (P<0.01). CONCLUSION: Immunoglobulin was significantly effective in the adjuvant treatment of children with severe pneumonia, and it can rapidly improve the improvement of symptoms, enhance immune function and inhibit inflammatory reaction; therefore it is worth promotion. |
format | Online Article Text |
id | pubmed-6659095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Professional Medical Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-66590952019-08-01 Injection of immunoglobulin in the treatment process of children with severe pneumonia Chen, Liping Qi, Xuehai Li, Ruiying Wang, Xudong Shi, Baohai Meng, Qingmei Pak J Med Sci Original Article OBJECTIVE: To observe the effect of intravenous infusion of immune globulin in the treatment of children with severe pneumonia. METHODS: Ninety-eight children with severe pneumonia who received treatment in our hospital between April 2015 and December 2016 were selected, and they were grouped into a control group and an treatment group, 49 each group. The control group received conventional treatment. The treatment group was additionally treated with immune globulin on the basis of conventional treatment. The humoral immune indicators were detected using immunoturbidimetric assay, and the inflammatory reaction indicators were detected using enzyme-linked immunoabsorbent kit. The overall efficacy, clinical symptoms, humoral immunity and inflammatory response were compared between the two groups. RESULTS: The total effective rate of the treatment group was significantly higher than that of the control group (P<0.05). The cough, rale and fever of the treatment group disappeared faster than those of the control group, the relief of cardiac failure was also faster in the treatment group (P<0.05). The immunoglobulin G (Ig G), Ig A and Ig M of patients in the two groups compared before treatment, and no significant difference was found (P>0.05). The Ig G level of the treatment group was higher than that of the control group after treatment (P<0.05). The comparison of Ig A and Ig M between the two groups indicated no significant difference (P>0.05). The two groups had no significant differences in the content of tumor necrosis factor (TNF)-α, C-reactive protein (CRP), soluble intercellular adhesion molecule (SICAM)-1 and interferon (IFN)-γ (P>0.05) before treatment, but the content of the treatment group was significantly higher than that of the control group (P<0.01). CONCLUSION: Immunoglobulin was significantly effective in the adjuvant treatment of children with severe pneumonia, and it can rapidly improve the improvement of symptoms, enhance immune function and inhibit inflammatory reaction; therefore it is worth promotion. Professional Medical Publications 2019 /pmc/articles/PMC6659095/ /pubmed/31372121 http://dx.doi.org/10.12669/pjms.35.4.83 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Chen, Liping Qi, Xuehai Li, Ruiying Wang, Xudong Shi, Baohai Meng, Qingmei Injection of immunoglobulin in the treatment process of children with severe pneumonia |
title | Injection of immunoglobulin in the treatment process of children with severe pneumonia |
title_full | Injection of immunoglobulin in the treatment process of children with severe pneumonia |
title_fullStr | Injection of immunoglobulin in the treatment process of children with severe pneumonia |
title_full_unstemmed | Injection of immunoglobulin in the treatment process of children with severe pneumonia |
title_short | Injection of immunoglobulin in the treatment process of children with severe pneumonia |
title_sort | injection of immunoglobulin in the treatment process of children with severe pneumonia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659095/ https://www.ncbi.nlm.nih.gov/pubmed/31372121 http://dx.doi.org/10.12669/pjms.35.4.83 |
work_keys_str_mv | AT chenliping injectionofimmunoglobulininthetreatmentprocessofchildrenwithseverepneumonia AT qixuehai injectionofimmunoglobulininthetreatmentprocessofchildrenwithseverepneumonia AT liruiying injectionofimmunoglobulininthetreatmentprocessofchildrenwithseverepneumonia AT wangxudong injectionofimmunoglobulininthetreatmentprocessofchildrenwithseverepneumonia AT shibaohai injectionofimmunoglobulininthetreatmentprocessofchildrenwithseverepneumonia AT mengqingmei injectionofimmunoglobulininthetreatmentprocessofchildrenwithseverepneumonia |